Genitourinary Cancer Efficacy and Safety of Darolutamide in ARASENS by Disease Volume and Risk: Phase 3 Study Mar 15, 2023
Genitourinary Cancer PROs in Cisplatin-Ineligible mUC Patients Treated with EV: EV-103 Cohort K Mar 15, 2023
Genitourinary Cancer Efficacy of Subsequent mCRPC Treatments After Apalutamide in nmCRPC Patients: SPARTAN Post-hoc Analysis Mar 15, 2023
Breast Cancer,HER2+ Fam-Trastuzumab Gains FDA Approval for HER2-Low Breast Cancer Treatment Mar 14, 2023
Breast Cancer,HER2+ HER2DX Test Correlates with Trastuzumab/Pertuzumab Therapy in HER2+/HR+ Breast Cancer Mar 14, 2023
